CME CIO Sunil Cutinho Sells $1.5M of Stock

By TradeTexts Research Desk Oct 27, 2026, 6:02 PM EDT

Key Points

Sunil Cutinho sold 5,000 shares of CME Group Inc. for a total of $1,493,500, reducing his ownership by about 20% to 20,037 shares.
CME Group's stock closed at $293.48 on the event date and has traded recently around $308.06, which is up about 5% since.
Analysts maintain a consensus 'buy' rating on CME Group, with a mean price target of $317.06, slightly above the recent trading price.

Get CME Group text alerts

We text you when insiders, Congress, analysts or big funds move on $CME.

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated CME Group Inc. alert may contain errors. Disclosures

On October 27, 2026, Sunil Cutinho, the Chief Information Officer of CME Group Inc. (CME), sold 5,000 shares at an average price of $298.70. This sale totaled $1,493,500 and reduced his ownership by about 20%, leaving him with 20,037 shares. This information comes from a Form 4 filing with the SEC.

Cutinho's sale comes as CME Group's stock has been performing well. On the same day, the stock closed at $293.48, while it has recently traded around $308.06, which is about 5% higher than the close on the event date.

CME CME Group Inc.

$308.06 +18.12% year to date

Daily close · Oct 26, 2026

Other Institutional Activity in CME Group

Miller Howard Investments increased its stake in CME Group by 33,169 shares, bringing its total to 192,542 shares worth approximately $50.4 million. Meanwhile, Carnegie Investment Counsel trimmed its holdings by 7,393 shares, now holding 152,288 shares valued at about $37.9 million. RMR Wealth Builders grew its position by 2,415 shares to a total of 20,190 shares worth about $5.3 million. In contrast, Marathon Asset Management reduced its stake by 7,675 shares, bringing its total down to 87,498 shares.

CME Group Inc. Stock Holds Steady

CME Group shares are currently trading well above their 50-day and 200-day moving averages, which stand at $278.14 and $279.61, respectively. The stock is also above its 52-week low of $218.31 and has a 52-week high of $329.16, making the recent price action notable.

Recent Earnings

CME Group reported trailing twelve-month revenue of approximately $6.96 billion, with a net margin of 63.5%. The company has a return on equity of 16.1%. Its next earnings report is scheduled for February 3, 2027.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

F 28/100

Reported Apr 22, 2026

Forward outlook
2 target cuts vs 0 raises.
EPS & revenue
EPS missed estimates by 1.2%. Revenue missed estimates by 1.6%.
Profit surprise
EBITDA missed by 6 percent. Operating income missed by 5 percent.
Pre-earnings setup
Expectations were about average.
Analyst signal
2 target cuts.
Earnings quality
Gross margin up 0.7 points. Operating margin up 2.2 points. Positive free cash flow.

Earnings Call Summary

CME delivered a record first quarter with average daily volume of 36.2 million contracts, up 22 percent year-over-year, marking the highest in company history. Revenue reached $1.88 billion, up 14 percent, with record performance across all six asset classes and international markets. The company achieved record adjusted operating margins of 72.8 percent and adjusted earnings per share of $3.36, returning $3.2 billion to shareholders through dividends and buybacks.

Guidance CME reaffirmed its full-year adjusted expense guidance of about $1.695 billion. The company expects to continue investing in technology and cloud migration while maintaining capital returns through dividends and share buybacks.

Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.

Analysts Set New Price Targets

On October 22, 2026, several firms maintained their ratings on CME Group. UBS kept a 'Neutral' rating with a target price of $310. Morgan Stanley maintained an 'Overweight' rating with a target of $359, while Barclays set a target of $321 with an 'Equal-Weight' rating. The consensus rating from analysts is a 'buy' with a mean price target of $317.06.

About CME Group

CME Group Inc. operates contract markets for trading futures and options on futures contracts globally. It offers a variety of products based on interest rates, equity indexes, and commodities, among others. This recent insider sale comes amid significant trading activity and analyst interest in the company.

Bottom Line

Sunil Cutinho's recent sale of CME shares is noteworthy, especially as the stock is trading near its recent highs. Investors should keep an eye on the upcoming earnings report and any further insider trades. The consensus rating remains strong, suggesting continued interest in CME Group's performance.